This disclosure describes a novel compounds and pharmaceutical compositions for inhibiting the TRPAl ion channel and/or medical conditions related to TRPAl, such as pain or asthma.
INHIBITING TRANSIENT RECEPTOR POTENTIAL ION CHANNEL TRPA1